VERICI DX PLC

Active Penarth

Other professional, scientific and technical activities n.e.c.

23 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
V

VERICI DX PLC

Other professional, scientific and technical activities n.e.c.

Founded 22 Apr 2020 Active Penarth, United Kingdom 23 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.

Previous Company Names

VERICI DX LIMITED 22 Apr 2020 — 9 Sept 2020
Accounts Submitted 7 Jul 2025 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 9 May 2025 Next due 5 May 2026 14 days remaining
Net assets £5M £2M 2024 year on year
Total assets £7M £2M 2024 year on year
Total Liabilities £2M £824K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

Avon House 19 Stanwell Road Penarth Cardiff CF64 2EZ United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for VERICI DX PLC (12567827), an active life sciences and medical technology company based in Penarth, United Kingdom. Incorporated 22 Apr 2020. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2020–2024)

Cash in Bank

£4.06M

Increased by £1.98M (+96%)

Net Assets

£5.26M

Increased by £2.47M (+88%)

Total Liabilities

£2.23M

Decreased by £823.53k (-27%)

Turnover

£3.34M

Increased by £2.54M (+320%)

Employees

23

Increased by 4 (+21%)

Debt Ratio

30%

Decreased by 22 (-42%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 1,371,646,311 Shares £22.85m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Jul 202587,765,264£439k£0.005
24 Jul 20251,183,087,396£5.92m£0.005
20 Feb 202472,222,222£6.50m£0.09
4 Mar 202228,571,429£10.00m£0.35

Officers

Officers

1 active 2 resigned
Status
Julian Huw BainesDirectorBritishUnited Kingdom6122 Apr 2020Active

Shareholders

Shareholders (16)

Icahn School Of Medicine At Mount Sinai, Inc.
11.4%
North Atlantic Smaller Companies Investment Trust Plc
9.5%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Renalytix Ai Plc

Ceased 3 Nov 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Apr 2026OfficersTermination of James Mccullough as director on 2026-03-31
13 Oct 2025OfficersTermination of Dr Erik Kristian Lium as director
9 Oct 2025OfficersTermination of Erik Kristian Lium as director on 2024-10-06
9 Oct 2025OfficersAppointment of Mr Aubrey Richard Powell as director on 2025-10-06
21 Aug 2025CapitalAllotment of shares (GBP 1,425,628.863) on 2025-07-24
2 Apr 2026 Officers

Termination of James Mccullough as director on 2026-03-31

13 Oct 2025 Officers

Termination of Dr Erik Kristian Lium as director

9 Oct 2025 Officers

Termination of Erik Kristian Lium as director on 2024-10-06

9 Oct 2025 Officers

Appointment of Mr Aubrey Richard Powell as director on 2025-10-06

21 Aug 2025 Capital

Allotment of shares (GBP 1,425,628.863) on 2025-07-24

Recent Activity

Latest Activity

Termination of James Mccullough as director on 2026-03-31

2 weeks ago on 2 Apr 2026

Termination of Dr Erik Kristian Lium as director

6 months ago on 13 Oct 2025

Termination of Erik Kristian Lium as director on 2024-10-06

6 months ago on 9 Oct 2025

Appointment of Mr Aubrey Richard Powell as director on 2025-10-06

6 months ago on 9 Oct 2025

Allotment of shares (GBP 1,425,628.863) on 2025-07-24

8 months ago on 21 Aug 2025